ArticleTherapeutic advances in medical oncology2026
Updated cost comparison of home care subcutaneous versus outpatient intravenous trastuzumab for HER2-positive breast cancer in Singapore.
Yanting Ouyang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.